0001209191-20-000814.txt : 20200103 0001209191-20-000814.hdr.sgml : 20200103 20200103160945 ACCESSION NUMBER: 0001209191-20-000814 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amello Jason CENTRAL INDEX KEY: 0001451805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 20505352 MAIL ADDRESS: STREET 1: 500 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 01824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0001069308 Acer Therapeutics Inc. ACER 0001451805 Amello Jason C/O ACER THERAPEUTICS INC. ONE GATEWAY CTR. STE. 351 NEWTON MA 02458 1 0 0 0 Stock Option (right to buy) 3.79 2020-01-02 4 A 0 9000 0.00 A 2030-01-02 Common Stock 9000 9000 D The option vests and becomes exercisable in full on January 2, 2021. /s/ Harry Palmin, Attorney-in-Fact 2020-01-03